Aflac Incorporated Q3 2025 Earnings Recap

Aflac Incorporated reported solid third-quarter 2025 results, with adjusted earnings per diluted share rising 15.3% year-over-year to $2.49, driven by strong sales performance in both Japan and the U.S.

Key Takeaways

• Aflac Japan recorded an impressive 11.8% year-over-year sales increase, notably fueled by a 42% surge in cancer insurance sales.
• New sales in Aflac U.S. reached $390 million, marking a 2.8% increase from the previous year, maintaining a strong premium persistency of 79%.
• Aflac repurchased a record $1 billion in shares and paid $309 million in dividends during the quarter, reinforcing its commitment to shareholder returns.
• The company celebrated 43 consecutive years of dividend increases, highlighting its strong financial position and capital management strategy.
• Continued emphasis on underwriting discipline and premium persistency is expected to drive further net earned premium growth, supporting the company’s long-term objectives.